Web Analytics

3 Latest Announced Rounds

  • $34,000,000
    Seed

    1 Investors

    Technology, Information and Internet
    Jul 4th, 2025
  • $5,500,000
    Seed

    1 Investors

    Software Development
    Jul 4th, 2025
  • $28,500,000
    Series A

    2 Investors

    Venture Capital and Private Equity Principals
    Jul 4th, 2025
$840.57M Raised in 47 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Vaxinano

start up
France - Loos, Hauts-de-France
  • 30/10/2024
  • Unknown
  • $6,503,959

Vaxinano is a clinical-stage biotechnology company, developing a new generation of nasally administered vaccines that are more efficient and faster to deploy to combat infectious diseases and new pandemics.

The vaccine is based on STELLAR-NP nanoparticles that confer highly stable, adjuvant-free solution for an effective and long-lasting response tot protect against the most difficult pathogens, such as parasites, viruses or bacteria...


Related People